The UW Clinical Research Core was initiated in 1988 to support pilot clinical trials proposed by UW junior faculty members of senior faculty initiating new research in the area of HIV. Since its inception it has supported 17 clinical trials enrolling over 900 patients. Over 20 publications have ensued from this work, and the pilot data have led to 8 funded research applications. In this funding period we propose to expand the UW CFAR to include both a Seattle based and Internationally based CRC. The Seattle based program will continue to emphasize short term limited support of interdisciplinary studies that are directed at the epidemiology and biology of HIV acquisition/transmission. One current effort is a detailed study of the immunologic and virologic aspects of acute subclinical primary HIV-1 infection. Within last few years, the UW has established several cohort studies in International sites that are directed at the transmission/acquisition of HIV infection. The International CRC will directed at improving the interdisciplinary aspects of these studies. CFAR International CRC resources will be devoted at supporting the acquisition, storage and shipment of specimens from these cohort studies of collaborating laboratory based investigators at the UW; especially those involved in retrovirology and immunology based research. To date, the request for CFAR CRC resources have far exceeded available resources. An Internal Scientific Review Committee consisting of the CFAR CRC resources have far exceeded available resources. An Internal Scientific Review Committee consisting of the CFAR Director, Associated Directors and the Internal Review Committee listed below will review concept sheets from CFAR investigators and prioritize the utilization and duration of CFAR resources for approval projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-12
Application #
6099405
Study Section
Project Start
1999-03-01
Project End
2000-02-29
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Fairbanks, Jade; Beima-Sofie, Kristin; Akinyi, Pamela et al. (2018) You Will Know That Despite Being HIV Positive You Are Not Alone: Qualitative Study to Inform Content of a Text Messaging Intervention to Improve Prevention of Mother-to-Child HIV Transmission. JMIR Mhealth Uhealth 6:e10671
Nevin, Paul E; Frey, Sarah; Lipira, Lauren et al. (2018) ""You are always hiding. It's the worst way to live."" Exploring Stigma in African Immigrants Living With HIV in a Large Northwest U.S. Metropolitan Area. J Assoc Nurses AIDS Care 29:417-425
Sauceda, John A; Wiebe, John S; Chan, Kiana et al. (2018) Acculturation, family cohesion, and mental health among Latinos living with HIV on the U.S.-Mexico border. Cultur Divers Ethnic Minor Psychol 24:453-458
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Suter, Megan K; Karr, Catherine J; John-Stewart, Grace C et al. (2018) Implications of Combined Exposure to Household Air Pollution and HIV on Neurocognition in Children. Int J Environ Res Public Health 15:
Jenness, Samuel M; Goodreau, Steven M; Morris, Martina (2018) EpiModel: An R Package for Mathematical Modeling of Infectious Disease over Networks. J Stat Softw 84:
Kraft, John C; McConnachie, Lisa A; Koehn, Josefin et al. (2018) Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation. J Control Release 275:229-241
Goodreau, Steven M; Hamilton, Deven T; Jenness, Samuel M et al. (2018) Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study. J Adolesc Health 62:311-319

Showing the most recent 10 out of 1275 publications